Matthew Austin

2.6k total citations
47 papers, 1.5k citations indexed

About

Matthew Austin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Matthew Austin has authored 47 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Matthew Austin's work include Bone health and treatments (6 papers), Atomic and Subatomic Physics Research (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Matthew Austin is often cited by papers focused on Bone health and treatments (6 papers), Atomic and Subatomic Physics Research (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Matthew Austin collaborates with scholars based in United States, United Kingdom and Canada. Matthew Austin's co-authors include Javier San Martín, Michael A. Bolognese, E. Michael Lewiecki, Yu Liu, Paul D. Miller, Michael R. McClung, Beiying Ding, Cesar Libanati, Jacques P. Brown and Henry G. Bone and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The American Journal of Medicine.

In The Last Decade

Matthew Austin

42 papers receiving 1.4k citations

Peers

Matthew Austin
Christina Bucci‐Rechtweg United States
Eduardo A. Vega United States
Jorge Arellano United States
Natalie Boytsov United States
Gabriella Farina Italy
Érick Moyneur United States
J. J. Nicoll United Kingdom
Giampaolo Talamo United States
Audrey A. Dawson United Kingdom
Jie Su Canada
Christina Bucci‐Rechtweg United States
Matthew Austin
Citations per year, relative to Matthew Austin Matthew Austin (= 1×) peers Christina Bucci‐Rechtweg

Countries citing papers authored by Matthew Austin

Since Specialization
Citations

This map shows the geographic impact of Matthew Austin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Austin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Austin more than expected).

Fields of papers citing papers by Matthew Austin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Austin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Austin. The network helps show where Matthew Austin may publish in the future.

Co-authorship network of co-authors of Matthew Austin

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Austin. A scholar is included among the top collaborators of Matthew Austin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Austin. Matthew Austin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dizman, Nazlı, Matthew Austin, Bryden Considine, et al.. (2023). Outcomes With Combination Pembrolizumab and Axitinib in Second and Further Line Treatment of Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer. 21(2). 221–229. 5 indexed citations
2.
Mann, Jacqueline E., Liliana E. Lucca, Matthew Austin, et al.. (2023). Abstract 2268: Single cell RNA sequencing defines dynamic immune cell subsets in serial colon and peripheral blood samples in a patient with checkpoint inhibitor-induced colitis. Cancer Research. 83(7_Supplement). 2268–2268.
3.
Jessel, Shlomit, Sarah A. Weiss, Matthew Austin, et al.. (2022). Immune Checkpoint Inhibitor-Induced Hypophysitis and Patterns of Loss of Pituitary Function. Frontiers in Oncology. 12. 836859–836859. 47 indexed citations
4.
McGarry, Kelly, Fred J. Schiffman, Matthew Austin, et al.. (2021). The State of Morning Report in the Current Healthcare Landscape: a National Survey of Internal Medicine Program Directors. Journal of General Internal Medicine. 37(7). 1665–1672. 6 indexed citations
5.
Weatherley, Nicholas, James Eaden, Paul Hughes, et al.. (2020). Quantification of pulmonary perfusion in idiopathic pulmonary fibrosis with first pass dynamic contrast-enhanced perfusion MRI. Thorax. 76(2). 144–151. 17 indexed citations
6.
Lewis, Robert A., Catherine Billings, Judith Hurdman, et al.. (2020). Maximal Exercise Testing Using the Incremental Shuttle Walking Test Can Be Used to Risk-Stratify Patients with Pulmonary Arterial Hypertension. Annals of the American Thoracic Society. 18(1). 34–43. 12 indexed citations
7.
Austin, Matthew, Peter J. Quesenberry, Corey E. Ventetuolo, Olin D. Liang, & John L. Reagan. (2019). Prevalence and Effect on Survival of Pulmonary Hypertension in Myelofibrosis. Clinical Lymphoma Myeloma & Leukemia. 19(9). 593–597. 10 indexed citations
8.
Weatherley, Nicholas, Neil J. Stewart, Ho‐Fung Chan, et al.. (2018). Hyperpolarised xenon magnetic resonance spectroscopy for the longitudinal assessment of changes in gas diffusion in IPF. Thorax. 74(5). 500–502. 44 indexed citations
9.
Chiou, Sy Han, Matthew Austin, Jing Qian, & Rebecca A. Betensky. (2018). Transformation model estimation of survival under dependent truncation and independent censoring. Statistical Methods in Medical Research. 28(12). 3785–3798. 16 indexed citations
10.
Billings, Catherine, Robert A. Lewis, Iain Armstrong, et al.. (2018). Incremental Shuttle Walking Test Distance Is Reduced in Patients With Pulmonary Hypertension in World Health Organisation Functional Class I. Frontiers in Medicine. 5. 172–172. 4 indexed citations
11.
Billings, Catherine, Judith Hurdman, Robin Condliffe, et al.. (2017). Incremental shuttle walk test distance and autonomic dysfunction predict survival in pulmonary arterial hypertension. The Journal of Heart and Lung Transplantation. 36(8). 871–879. 16 indexed citations
12.
Wirth, Kathleen E., Denis Agniel, Christopher D. Barr, Matthew Austin, & Victor DeGruttola. (2015). A composite likelihood approach for estimating HIV prevalence in the presence of spatial variation. Statistics in Medicine. 34(28). 3750–3759. 3 indexed citations
13.
Austin, Matthew, Mark Mellow, & William M. Tierney. (2014). Fecal Microbiota Transplantation in the Treatment of Clostridium difficile Infections. The American Journal of Medicine. 127(6). 479–483. 56 indexed citations
14.
Zebaze, Roger, Cesar Libanati, Matthew Austin, et al.. (2013). Differing effects of denosumab and alendronate on cortical and trabecular bone. Bone. 59. 173–179. 124 indexed citations
15.
Austin, Matthew & Rebecca A. Betensky. (2013). Eliminating bias due to censoring in Kendall’s tau estimators for quasi-independence of truncation and failure. Computational Statistics & Data Analysis. 73. 16–26. 5 indexed citations
16.
Seeman, Ego, Cesar Libanati, Matthew Austin, et al.. (2012). THE TRANSITORY PTH INCREASE FOLLOWING DENOSUMAB ADMINISTRATION IS ASSOCIATED WITH REDUCED INTRACORTICAL POROSITY: A DISTINCTIVE CHARACTERISTIC OF DENOSUMAB THERAPY. Osteoporosis International. 23. 1 indexed citations
17.
Zebaze, Roger, Cesar Libanati, Matthew Austin, John P. Bilezikian, & Ego Seeman. (2012). DENOSUMAB REDUCES INTRACORTICAL POROSITY MORE THAN ALENDRONATE IN THE COMPACT-APPEARING CORTEX AND OUTER TRANSITIONAL ZONE. Osteoporosis International. 23. 1 indexed citations
18.
Genant, Harry K., Klaus Engelke, David A. Hanley, et al.. (2010). Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral density. Bone. 47(1). 131–139. 58 indexed citations
19.
Brown, Jacques P., Richard L. Prince, Chad Deal, et al.. (2008). Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial. Journal of Bone and Mineral Research. 24(1). 153–161. 436 indexed citations
20.
Smith, Robert E., John A. Glaspy, N. Simon Tchekmedyian, Matthew Austin, & Joel Kallich. (2003). Hemoglobin Increase Is Associated with Improved Health-Related Quality of Life in Patients with Cancer Not Receiving Chemotherapy. PubMed. 1(1). 49–54. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina Bucci‐Rechtweg Breakdown of academic impact, for papers by Eduardo A. Vega Breakdown of academic impact, for papers by Jorge Arellano Breakdown of academic impact, for papers by Natalie Boytsov Breakdown of academic impact, for papers by Gabriella Farina Breakdown of academic impact, for papers by Érick Moyneur Breakdown of academic impact, for papers by J. J. Nicoll Breakdown of academic impact, for papers by Giampaolo Talamo Breakdown of academic impact, for papers by Audrey A. Dawson Breakdown of academic impact, for papers by Jie Su
Rankless by CCL
2026